# Phosphoproteomic Profile of Children With Down Syndrome

> **NCT06279208** · — · COMPLETED · sponsor: **Perha Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Down Syndrome

## Interventions

- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT06279208
- **Lead sponsor:** Perha Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-18
- **Primary completion:** 2025-04-16
- **Final completion:** 2025-04-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279208, "Phosphoproteomic Profile of Children With Down Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06279208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*